Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma

Key Points

• Consolidation reduced-dose whole-brain radiation therapy shows efficacy in patients with primary central nervous system lymphoma.
• Patients receiving response-adapted boost experienced enhanced therapeutic effects and reduced side effects.
• This analysis utilized advanced imaging techniques to tailor radiation treatment regimens in older populations.
• Findings support the potential for optimized radiation protocols to improve care in this vulnerable group.